Indy Hematology Review Presentation Archive 2018 State of the Art: Treatments, Targets, and Diagnosis – Ruemu E. Birhiray, MD Multiple Myeloma: Emerging therapies – Kenneth Anderson, MD Multiple Myeloma: What I recommend and how you should treat – Kenneth Anderson, MD Waldenström’s Macroglobulinemia: Emerging options and current treatment paradigms – Steven Treon, MD, MA, PhD Not so Benign Hematology – Robert Brodsky, MD Benign Hematology: Coagulopathies and Beyond – Craig Kessler, MD Indolent Lymphomas and Hodgkin’s Lymphoma: My treatment and emerging strategies – Bruce Cheson, MD, FACP, FAAS, FASCO Aggressive B and T Cell Lymphomas: Treatment Paradigms in 2018 – John Leonard, MD Challenging Cases Presentation – Michael C. Wiemann, MD – Co-Chair Chronic Myeloid Leukemia – Richard Larson, MD Beyond JAK 2: Mastocytosis, CMML, Eosinophilic and Neutrophilic leukemia; Treatments, Paradigms, and Diagnosis – Ayalew Tefferi, MD, PhD Myeloproliferative Neoplasms: What about JAK? PV, ET, MF – John Mascarenhas, MD, MS Acute Myeloid Leukemias: Targets and Curability, so close but a journey so far – Martin Tallman, MD Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome: CARS, CARTS, Mechanics, and beyond – Elias Jabbour, MD Hematopoietic Stem Cell Transplantation: How I treat and when I transplant in 2018 – Richard Childs, MD, RADM, USPHS
